|
WO2020183238A1
|
|
Reversible coating of chitosan-nucleic acid nanoparticles and methods of their use
|
|
AU2017356350A1
|
|
Intestinal expression of programmed death ligand 1
|
|
CA2925198A1
|
|
Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo
|
|
EP2828332A1
|
|
Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo
|
|
NZ726436A
|
|
Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo
|
|
CA2794923A1
|
|
Highly acidic chitosan-nucleic acid polyplex compositions
|
|
MX2010003323A
|
|
High concentration chitosan-nucleic acid polyplex compositions.
|
|
EP2034954A2
|
|
Non-viral compositions and methods for transfecting gut cells in vivo
|
|
CA2503422A1
|
|
Compositions for cancer treatment
|
|
CA2403205A1
|
|
Compositions and methods of regulated protein expression in gut endocrine k cells
|
|
EP1889914A1
|
|
Compositions for gene therapy of diabetes
|
|
EP1153131A2
|
|
Compositions for gene therapy of diabetes
|
